Harmony Biosciences Holdings, Inc.
NASDAQ:HRMY
38.34 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 582.022 | 437.855 | 305.44 | 159.742 | 5.995 | 0 |
| Cost of Revenue
| 121.236 | 83.481 | 55.518 | 27.738 | 1.577 | 0.184 |
| Gross Profit
| 460.786 | 354.374 | 249.922 | 132.004 | 4.418 | -0.184 |
| Gross Profit Ratio
| 0.792 | 0.809 | 0.818 | 0.826 | 0.737 | 0 |
| Reseach & Development Expenses
| 76.063 | 70.886 | 30.367 | 19.448 | 69.595 | 12.372 |
| General & Administrative Expenses
| 95.289 | 84.017 | 63.909 | 39.746 | 36.409 | 12.206 |
| Selling & Marketing Expenses
| 97.404 | 79.285 | 68.118 | 55.824 | 44.318 | 16.861 |
| SG&A
| 192.693 | 163.302 | 132.027 | 95.57 | 80.727 | 29.067 |
| Other Expenses
| 0.159 | 0.169 | 0.016 | -3.071 | 0 | 0 |
| Operating Expenses
| 268.756 | 234.188 | 162.394 | 115.018 | 150.322 | 41.439 |
| Operating Income
| 192.03 | 120.186 | 68.704 | 3.678 | -145.904 | -41.439 |
| Operating Income Ratio
| 0.33 | 0.274 | 0.225 | 0.023 | -24.338 | 0 |
| Total Other Income Expenses Net
| -9.607 | -15.5 | -31.276 | -40.622 | -6.073 | 1.541 |
| Income Before Tax
| 173.396 | 104.686 | 37.428 | -36.944 | -151.977 | -39.898 |
| Income Before Tax Ratio
| 0.298 | 0.239 | 0.123 | -0.231 | -25.351 | 0 |
| Income Tax Expense
| 44.543 | -76.782 | 2.831 | 14.912 | 6.073 | 1.541 |
| Net Income
| 128.853 | 181.468 | 34.597 | -51.856 | -158.05 | -39.898 |
| Net Income Ratio
| 0.221 | 0.414 | 0.113 | -0.325 | -26.364 | 0 |
| EPS
| 2.17 | 3.07 | 0.6 | -0.91 | -2.48 | -0.81 |
| EPS Diluted
| 2.13 | 2.97 | 0.58 | -0.91 | -2.48 | -0.81 |
| EBITDA
| 231.278 | 120.355 | 87.544 | 13.915 | -142.694 | -41.255 |
| EBITDA Ratio
| 0.397 | 0.275 | 0.287 | 0.087 | -23.802 | 0 |